久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/09/05 | 3,430 | 3,455 | 3,410 | 3,435 | -10 | -0.3% | 114,900 |
2022/09/02 | 3,440 | 3,470 | 3,415 | 3,445 | +60 | +1.8% | 247,900 |
2022/09/01 | 3,355 | 3,415 | 3,355 | 3,385 | -5 | -0.1% | 128,300 |
2022/08/31 | 3,360 | 3,400 | 3,360 | 3,390 | -5 | -0.1% | 139,900 |
2022/08/30 | 3,345 | 3,395 | 3,345 | 3,395 | ±0 | ±0% | 160,600 |
2022/08/29 | 3,360 | 3,405 | 3,350 | 3,395 | -30 | -0.9% | 366,300 |
2022/08/26 | 3,440 | 3,440 | 3,410 | 3,425 | -10 | -0.3% | 124,600 |
2022/08/25 | 3,415 | 3,440 | 3,410 | 3,435 | +30 | +0.9% | 96,100 |
2022/08/24 | 3,405 | 3,425 | 3,395 | 3,405 | -10 | -0.3% | 93,000 |
2022/08/23 | 3,415 | 3,430 | 3,405 | 3,415 | -40 | -1.2% | 99,300 |
2022/08/22 | 3,435 | 3,455 | 3,420 | 3,455 | ±0 | ±0% | 114,900 |
2022/08/19 | 3,455 | 3,465 | 3,425 | 3,455 | +40 | +1.2% | 129,500 |
2022/08/18 | 3,450 | 3,455 | 3,410 | 3,415 | -40 | -1.2% | 86,700 |
2022/08/17 | 3,440 | 3,455 | 3,420 | 3,455 | +30 | +0.9% | 119,000 |
2022/08/16 | 3,445 | 3,445 | 3,405 | 3,425 | -10 | -0.3% | 122,100 |
2022/08/15 | 3,440 | 3,465 | 3,430 | 3,435 | +25 | +0.7% | 145,200 |
2022/08/12 | 3,420 | 3,450 | 3,390 | 3,410 | -5 | -0.1% | 147,300 |
2022/08/10 | 3,350 | 3,415 | 3,340 | 3,415 | +75 | +2.2% | 132,500 |
2022/08/09 | 3,370 | 3,385 | 3,340 | 3,340 | -35 | -1% | 231,100 |
2022/08/08 | 3,400 | 3,400 | 3,370 | 3,375 | -40 | -1.2% | 99,300 |
2022/08/05 | 3,385 | 3,425 | 3,380 | 3,415 | +10 | +0.3% | 115,400 |
2022/08/04 | 3,420 | 3,425 | 3,385 | 3,405 | +30 | +0.9% | 131,800 |
2022/08/03 | 3,375 | 3,405 | 3,360 | 3,375 | ±0 | ±0% | 142,400 |
2022/08/02 | 3,490 | 3,490 | 3,375 | 3,375 | -145 | -4.1% | 222,000 |
2022/08/01 | 3,455 | 3,530 | 3,440 | 3,520 | +60 | +1.7% | 137,100 |
2022/07/29 | 3,575 | 3,575 | 3,450 | 3,460 | -95 | -2.7% | 176,700 |
2022/07/28 | 3,590 | 3,590 | 3,530 | 3,555 | -15 | -0.4% | 109,500 |
2022/07/27 | 3,590 | 3,615 | 3,570 | 3,570 | -20 | -0.6% | 101,800 |
2022/07/26 | 3,620 | 3,620 | 3,580 | 3,590 | -35 | -1% | 117,000 |
2022/07/25 | 3,610 | 3,625 | 3,590 | 3,625 | +5 | +0.1% | 110,300 |
2022/07/22 | 3,600 | 3,640 | 3,575 | 3,620 | +20 | +0.6% | 197,900 |
2022/07/21 | 3,540 | 3,600 | 3,535 | 3,600 | ±0 | ±0% | 139,100 |
2022/07/20 | 3,490 | 3,600 | 3,470 | 3,600 | +175 | +5.1% | 316,700 |
2022/07/19 | 3,440 | 3,450 | 3,370 | 3,425 | -10 | -0.3% | 163,500 |
2022/07/15 | 3,450 | 3,470 | 3,415 | 3,435 | +25 | +0.7% | 136,500 |
2022/07/14 | 3,365 | 3,420 | 3,355 | 3,410 | +35 | +1% | 158,900 |
2022/07/13 | 3,350 | 3,395 | 3,350 | 3,375 | +10 | +0.3% | 176,600 |
2022/07/12 | 3,450 | 3,475 | 3,355 | 3,365 | -100 | -2.9% | 211,700 |
2022/07/11 | 3,460 | 3,470 | 3,395 | 3,465 | +85 | +2.5% | 291,700 |
2022/07/08 | 3,350 | 3,410 | 3,275 | 3,380 | -95 | -2.7% | 419,500 |
2022/07/07 | 3,485 | 3,500 | 3,455 | 3,475 | +35 | +1% | 137,700 |
2022/07/06 | 3,380 | 3,460 | 3,380 | 3,440 | +40 | +1.2% | 168,400 |
2022/07/05 | 3,440 | 3,440 | 3,385 | 3,400 | -40 | -1.2% | 177,800 |
2022/07/04 | 3,515 | 3,535 | 3,435 | 3,440 | -5 | -0.1% | 86,700 |
2022/07/01 | 3,525 | 3,545 | 3,425 | 3,445 | -50 | -1.4% | 125,700 |
2022/06/30 | 3,515 | 3,545 | 3,480 | 3,495 | +5 | +0.1% | 148,700 |
2022/06/29 | 3,475 | 3,505 | 3,440 | 3,490 | -45 | -1.3% | 436,300 |
2022/06/28 | 3,455 | 3,535 | 3,415 | 3,535 | +65 | +1.9% | 203,800 |
2022/06/27 | 3,535 | 3,535 | 3,420 | 3,470 | -15 | -0.4% | 168,400 |
2022/06/24 | 3,490 | 3,500 | 3,430 | 3,485 | +30 | +0.9% | 166,300 |
651~
700
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム